Progesterone receptor regulates Bcl-2 gene expression through direct binding to its promoter region in uterine leiomyoma cells

  • J Clin Endocrinol Metab. 2007 Nov;92(11):4459-66. doi: 10.1210/jc.2007-0725.
Ping Yin  1 ,  Zhihong Lin ,  You-Hong Cheng ,  Erica E Marsh ,  Hiroki Utsunomiya ,  Hiroshi Ishikawa ,  Qing Xue ,  Scott Reierstad ,  Joy Innes ,  Stephen Thung ,  J Julie Kim ,  Eugene Xu ,  Serdar E Bulun
Affiliations
  • 1. Division of Reproductive Biology Research, Department of Obstetrics and Gynecology, Feinberg School of Medicine at Northwestern University, Chicago, Illinois 60611, USA.
PMID: 17785366 DOI: 10.1210/jc.2007-0725
Abstract

Context: Uterine leiomyomas are smooth muscle cell Tumors that cause irregular uterine bleeding and pregnancy loss in many reproductive-age women. Progesterone stimulates their growth, whereas treatment with Progesterone Receptor (PR) antagonists or selective Progesterone Receptor modulators shrinks these Tumors. Molecular mechanisms underlying these observations are unknown.

Objective: Bcl-2 is a key protein that inhibits Apoptosis. It was proposed that growth enhancement of leiomyoma cells by progesterone was mediated via Bcl-2 induction. Here we test the hypothesis that PR regulates the Bcl-2 gene by directly binding to its promoter.

Results: The pure progesterone agonist R5020 increased the total number of viable primary human leiomyoma smooth muscle (LSM) cells in culture. Progesterone or R5020 (10(-6) m) significantly increased Bcl-2 mRNA levels after 2 and 4 h by 9.2- and 3.4-fold, respectively, in LSM cells. Transient transfection with deletion mutants of Bcl-2 promoter showed that the -1281/-258-bp region conferred responsiveness to progesterone induction in the presence of PR-A. We identified a palindromic progesterone response element (PRE) at -553/-539 bp. EMSA showed that PR in nuclear extracts from LSM cells bound specifically to this PRE. Chromatin immunoprecipitation-PCR confirmed in situ recruitment of PR to the -629/-388-bp region bearing the PRE. In vivo, Bcl-2 mRNA levels correlated significantly with total PR mRNA levels in leiomyoma tissues.

Conclusion: Taken together, progesterone via PR interacts with the Bcl-2 promoter to induce its expression in leiomyoma tissue. This may explain, in part, the progesterone-dependent enhancement of growth in uterine leiomyoma.